Intellectus Partners, LLC Illumina, Inc. Transaction History

Intellectus Partners, LLC

$383 Million
Q3 2024

A detailed history of Intellectus Partners, LLC transactions in Illumina, Inc. stock. As of the latest transaction made, Intellectus Partners, LLC holds 15,440 shares of ILMN stock, worth $2.21 Million. This represents 0.53% of its overall portfolio holdings.

Number of Shares

15,440

Previous 13,505 14.33%

Holding current value

$2.21 Million

Previous $1.41 Million 42.87%

% of portfolio

0.53%

Previous 0.39%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	BUY	$105.28 - $135.9 $203,716 - $262,966	1,935 Added 14.33%	15,440 $2.01 Million
Q2 2024 Jul 18, 2024	SELL	$101.05 - $133.57 $155,920 - $206,098	-1,543 Reduced 10.25%	13,505 $1.41 Million
Q1 2024 May 03, 2024	SELL	$127.73 - $147.2 $146,889 - $169,280	-1,150 Reduced 7.1%	15,048 $2.07 Million
Q4 2023 Feb 05, 2024	SELL	$92.79 - $142.53 $158,485 - $243,441	-1,708 Reduced 9.54%	16,198 $2.26 Million
Q3 2023 Oct 25, 2023	SELL	$128.91 - $192.44 $14,566 - $21,745	-113 Reduced 0.63%	17,906 $2.46 Million
Q2 2023 Jul 31, 2023	BUY	$183.43 - $232.67 $534,698 - $678,233	2,915 Added 19.3%	18,019 $3.38 Million
Q1 2023 May 04, 2023	BUY	$193.75 - $232.55 $28,481 - $34,184	147 Added 0.98%	15,104 $3.51 Million
Q4 2022 Feb 02, 2023	BUY	$187.24 - $242.74 $108,973 - $141,274	582 Added 4.05%	14,957 $3.02 Million
Q3 2022 Nov 14, 2022	BUY	$177.23 - $227.44 $51,751 - $66,412	292 Added 2.07%	14,375 $2.74 Million
Q2 2022 Aug 12, 2022	SELL	$181.58 - $368.0 $53,021 - $107,456	-292 Reduced 2.03%	14,083 $2.6 Million
Q1 2022 May 16, 2022	SELL	$303.87 - $423.8 $240,361 - $335,225	-791 Reduced 5.22%	14,375 $5.02 Million
Q4 2021 Feb 14, 2022	SELL	$347.28 - $421.83 $182,322 - $221,460	-525 Reduced 3.35%	15,166 $5.77 Million
Q3 2021 Nov 16, 2021	SELL	$405.61 - $524.84 $262,429 - $339,571	-647 Reduced 3.96%	15,691 $6.36 Million
Q2 2021 Aug 13, 2021	SELL	$372.84 - $481.5 $37,656 - $48,631	-101 Reduced 0.61%	16,338 $7.73 Million
Q1 2021 May 17, 2021	BUY	$361.28 - $504.76 $622,124 - $869,196	1,722 Added 11.7%	16,439 $6.31 Million
Q4 2020 Feb 18, 2021	BUY	$292.7 - $370.96 $3.85 Million - $4.88 Million	13,166 Added 848.87%	14,717 $5.45 Million
Q4 2020 Feb 12, 2021	SELL	$292.7 - $370.96 $3.27 Million - $4.14 Million	-11,162 Reduced 87.8%	1,551 $5.45 Million
Q3 2020 Nov 16, 2020	BUY	$268.51 - $400.74 $656,238 - $979,408	2,444 Added 23.8%	12,713 $3.93 Million
Q2 2020 Aug 14, 2020	BUY	$256.46 - $373.01 $73,604 - $107,053	287 Added 2.88%	10,269 $3.8 Million
Q1 2020 May 14, 2020	SELL	$209.2 - $335.53 $19,874 - $31,875	-95 Reduced 0.94%	9,982 $2.73 Million
Q4 2019 Jan 24, 2020	BUY	$288.29 - $335.49 $610,309 - $710,232	2,117 Added 26.6%	10,077 $3.34 Million
Q3 2019 Oct 11, 2019	BUY	$266.84 - $378.23 $29,085 - $41,227	109 Added 1.39%	7,960 $2.42 Million
Q2 2019 Aug 08, 2019	SELL	$300.59 - $368.15 $3,005 - $3,681	-10 Reduced 0.13%	7,851 $2.89 Million
Q1 2019 May 15, 2019	BUY	$272.57 - $321.18 $62,691 - $73,871	230 Added 3.01%	7,861 $2.44 Million
Q4 2018 Feb 14, 2019	SELL	$272.46 - $366.54 $381,444 - $513,156	-1,400 Reduced 15.5%	7,631 $2.29 Million
Q3 2018 Nov 15, 2018	SELL	$279.04 - $367.06 $54,970 - $72,310	-197 Reduced 2.13%	9,031 $3.32 Million
Q2 2018 Aug 14, 2018	SELL	$228.17 - $292.07 $62,290 - $79,735	-273 Reduced 2.87%	9,228 $2.58 Million
Q1 2018 May 15, 2018	SELL	$209.54 - $253.91 $389,115 - $471,510	-1,857 Reduced 16.35%	9,501 $2.25 Million
Q4 2017 Feb 13, 2018	BUY	$202.23 - $230.03 $404 - $460	2 Added 0.02%	11,358 $2.48 Million
Q3 2017 Nov 14, 2017	BUY	$172.3 - $213.93 $98,727 - $122,581	573 Added 5.31%	11,356 $2.26 Million
Q2 2017 Aug 15, 2017	BUY	N/A	10,783	10,783 $1.87 Million

Others Institutions Holding ILMN

# of Institutions

901

Shares Held

137M

Call Options Held

1.22M

Put Options Held

1.43M

View Full List

About ILLUMINA, INC.

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $22.5B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

More about ILMN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Intellectus Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Intellectus Partners, LLC with notifications on news.

Account

Intellectus Partners, LLC Illumina, Inc. Transaction History